Schedule 13D ownership disclosure
RVL PHARMACEUTICALS PLC
Security class unavailable · CUSIP: G6S41R101
Event date: 2023-01-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 23,730,864
- Percent of class
- 23.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-008067
- Form type
- SC 13D
- Filer
- Avista Healthcare Partners GP, Ltd.
- CIK
- CIK 1799895
- Filed
- Jan 30, 2023
- Reporting period
- Jan 27, 2023
- Description
- Schedule 13D beneficial ownership